Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare to Sell Fujifilm Imaging Systems

NEW YORK (GenomeWeb News) – General Electric unit GE Healthcare announced today that it has entered into a strategic alliance agreement with Fujifilm.

Under the agreement, Fujifilm will develop, manufacture, and supply biomolecular imaging systems to GE Healthcare, which will sell the products in life science and drug discovery markets around the world under the GE brand.

Fujifilm has developed a range of biomolecular imaging products over the years — from digital autoradiography devices to CCD camera systems. GE Healthcare, meanwhile, has introduced various non-radioactive biomolecular labeling and detection products.

In a statement today, Fujifilm Director and General Manager of the Life Science Products Division Yuzo Toda said that the agreement with GE Healthcare will combine Fujifilm's technology, R&D, and manufacturing with GE Healthcare's presence as a reagent and instrument supplier.

"By forming the alliance, both companies will make the most of our complementary capabilities to continue to the advancement of genomic and protein research," he said.

Nigel Darby, general manager of biotechnologies, life sciences at GE Healthcare, said that the FujiFilm products "fit well with our proprietary labeling technologies and the adjacent fields in the imaging workflow that GE Healthcare currently addresses."

Financial and other terms of the agreement were not disclosed.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.